跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸厄洛替尼片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Erlotinib Hydrochloride Tablets
Approved
化学药品
Erlotinib Hydrochloride Tablets
DR. REDDY'S LABORATORIES LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Oct 22, 2024
Approval ID
8eIk8NNvTRo
Company
DR. REDDY'S LABORATORIES LIMITED
Type
化学药品
Approval Details
Approval Id
8eIk8NNvTRo
Approval Number
国药准字HJ20240115
Generic Name
盐酸厄洛替尼片
Generic Name En
Erlotinib Hydrochloride Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
150mg(按C₂₂H₂₃N₃O₄ 计)
Reg Date
2024-10-22
Expired Date
2029-10-21
Company Name
DR. REDDY'S LABORATORIES LIMITED
Production Company Name
DR. REDDY'S LABORATORIES LIMITED
Company Detail Path
/organization/dr-reddys-laboratories-limited
Production Company Detail Path
/organization/dr-reddys-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 22, 2024
Approval ID
8eIk8NNvTRo
Type
化学药品
Back to NMPA Approvals